<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638350/" ref="ordinalpos=3488&amp;ncbi_uid=4857434&amp;link_uid=PMC3638350" image-link="/pmc/articles/PMC3638350/figure/F5/" class="imagepopup">Figure 5.  From: Restoring KLF5 in Esophageal Squamous Cell Cancer Cells Activates the JNK <span class="highlight" style="background-color:">Pathway</span> Leading to Apoptosis and Reduced Cell Survival. </a></div><br /><div class="p4l_captionBody">A model for the effects of KLF5 on cell survival and apoptosis in ESCC. When KLF5 is restored in ESCC cells, KLF5 trans-activates ASK1 and MKK4 to activate the JNK pathway. Activated JNK signaling then phosphorylates 14-3-3 proteins, leading to BAX release and translocation to the mitochondria, to promote apoptosis. In addition, KLF5 can directly transactivate BAX to increase BAX levels.</div></div>